Zheming Lu

6PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsElectrical energy transmission, networks and systemsTissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 29, 2026
MMP3 overexpression enhances CAR-T cell infiltration and antitumor activity in a CAF-enriched solid tumor model.

Yuge Zhu, Jiaxin Tu, Shance Li

|Feb 22, 2023
T cells engineered with full-length NKG2D linked to signaling domains of 4-1BB and CD3ζ show enhanced antitumor activity.

Xia Teng, Zhuona Rong, Shance Li

|Oct 28, 2022
Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes.

Chaoting Zhang, Yizhe Sun, Shance Li

|Oct 03, 2022
Autophagic flux restoration of senescent T cells improves antitumor activity of TCR-engineered T cells.

Chaoting Zhang, Yizhe Sun, Shance Li

|Jul 02, 2021
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies.

Chaoting Zhang, Qin Tan, Shance Li

|Jan 25, 2018
Mutation analysis of the EBV-lymphoblastoid cell line cautions their use as antigen-presenting cells.

Qin Tan, Wenjing Ku, Chaoting Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Yuge Zhu

1 joint publications

Jiaxin Tu

1 joint publications

Shance Li